Overview Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS for HandiHaler® in Healthy Male Volunteers Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary To investigate safety, tolerability, and pharmacokinetics of BIBW 2948 BS after repeated dosing Phase: Phase 1 Details Lead Sponsor: Boehringer Ingelheim